Trump administration defends Medicare drug price talks in case brought by Novartis Some see the filing as a sign the Trump administration is willing to maintain the controversial program

https://www.statnews.com/pharmalot/2025/02/20/trump-medicare-pharma-medicines-novartis-negotiations-prices/